Skip to main content

Gilead Joining the Global Access to Oncology Medicines Coalition

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

We’re pleased to announce that we're joining the global Access to Oncology Medicines (ATOM) Coalition to help improve care and access to essential cancer medicines in low- and lower middle-income countries. https://gilead.inc/39Gb9nb

About Gilead

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

View original content here

Tweet me: .@GileadSciences announces they are joining the global Access to Oncology Medicines (ATOM) Coalition. Read more here: https://bit.ly/3PHkf3F

KEYWORDS: NYSE: GILD, Gilead Sciences, ATOM

"Making strides against cancer in low- and lower middle- income countries will require not only innovative therapies, but also bold strategies built on the power of partnerships and working across the continuum of care - starting from disease awareness and prevention, to diagnosis and treatment, all the way to disease management." Mike Boyd Senior Vice President Gilead logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  251.04
-2.96 (-1.17%)
AAPL  269.81
+0.76 (0.28%)
AMD  254.44
-5.20 (-2.00%)
BAC  53.52
-0.04 (-0.07%)
GOOG  278.39
-5.73 (-2.02%)
META  632.62
-5.09 (-0.80%)
MSFT  513.18
-3.85 (-0.74%)
NVDA  200.82
-6.06 (-2.93%)
ORCL  250.67
-7.18 (-2.78%)
TSLA  451.03
-17.34 (-3.70%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.